FdaApplication
ANDA 212396
Identifiers
- fda_app_no: ANDA212396
Properties
| Property | Value |
|---|---|
| applicant_name | TIANJIN KINGYORK PHARMACEUTICALS CO LTD |
| application_type | ANDA |
| approval_date | 2021-04-20 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHYLPREDNISOLONE SODIUM SUCCINATE | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 40MG BASE/VIAL | INJECTABLE;INJECTION |
| METHYLPREDNISOLONE SODIUM SUCCINATE | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 125MG BASE/VIAL | INJECTABLE;INJECTION |
| METHYLPREDNISOLONE SODIUM SUCCINATE | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION |
| METHYLPREDNISOLONE SODIUM SUCCINATE | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
| METHYLPREDNISOLONE SODIUM SUCCINATE | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION |
5 products